FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance

Jul.30.2025
FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance
FDA Commissioner Robert Califf urged the DEA to classify 7-OH, an opioid-like compound found in vapes, drinks, and gummies, as a Schedule I substance. The FDA plans national warnings for doctors and tighter control of high concentrations.

Key points:

 

·FDA recommends: FDA Commissioner Marty Makary announced that 7-hydroxymitragynine (7-OH) will be classified as a controlled substance due to its opioid-like properties. 

 

·Widespread availability: 7-OH can be found in e-cigarette stores, beverages, and children's gummies. 

 

·Regulatory measures: FDA recommends that 7-hydroxymitragynine above a certain concentration threshold be classified as a Schedule I controlled substance. 

 

·Public education: FDA has issued a report and warned healthcare providers, emphasizing the risks of abuse associated with 7-OH.

 


 

【2Firsts News Flash】On July 30th, according to Reuters, Marty Makary, director of the FDA, suggested that 7-hydroxymitragynine (7-OH) be classified as a controlled substance due to its opiate-like properties.

 

He stated at a press conference held at the Department of Health and Human Services in Washington D.C. that many products containing 7-OH are sold in e-cigarette stores, and this compound is also present in beverages and children's gummy candies.

 

The FDA's letter to the DEA will recommend classifying 7-OH above a certain concentration threshold as a Schedule I controlled substance.

 

The FDA stated that the abuse potential of 7-OH is increasingly being scrutinized due to its ability to bind to opioid receptors.

 

"It is sold in e-cigarette shops, tobacco shops, convenience stores, and gas stations across the United States," said Macari.

 

The FDA is in the process of releasing a report and sending warning letters to every doctor in America. Markari stated that the FDA will continue its efforts to educate the public.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06
Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”
Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”
Brazil’s Federal Public Prosecutor’s Office (MPF) has filed a public civil action seeking to compel the federal government and Anvisa to establish a strict, enforceable regulatory framework for electronic smoking devices, replacing the current blanket ban. The lawsuit calls for mandatory product registration, nicotine caps, bans on youth-targeted advertising, and clear health warnings on packaging, and demands a national consumption report and an implementation timetable within 90 days.
Jan.30 by 2FIRSTS.ai
IQOS Partners with Mexico’s Zamna Festival; PMI Says Adult User Base Tops 140,000
IQOS Partners with Mexico’s Zamna Festival; PMI Says Adult User Base Tops 140,000
Philip Morris International (PMI) said IQOS, via its “IQOS Curious X” platform, has entered a global partnership with the Zamna music festival in Tulum, Mexico, with the collaboration making its on-site debut during Zamna 2026 and targeting adult nicotine users. PMI said IQOS has more than 34 million users worldwide, while the number of adult consumers in Mexico has surpassed 140,000.
Jan.15 by 2FIRSTS.ai
Guam names retailers fined for selling tobacco to under-21 customers; penalties range from $2,000 to $4,000
Guam names retailers fined for selling tobacco to under-21 customers; penalties range from $2,000 to $4,000
Guam disclosed enforcement details for its 2025 tobacco retail compliance program, showing a 97.1% compliance rate among 277 inspected retailers. Nine violations were recorded, including eight underage sales cases and one signage violation, with fines ranging from $500 to $4,000.
Feb.10 by 2FIRSTS.ai
Azerbaijan Parliament Passes E-cigarette Ban Bill in First Reading
Azerbaijan Parliament Passes E-cigarette Ban Bill in First Reading
Azerbaijan’s Milli Majlis has approved, in its first reading, a bill that would ban the import, export, production, storage, wholesale and retail sale, and use of electronic cigarettes and their components. The bill amends the Law on Tobacco and Tobacco Products, classifying nicotine-containing e-cigarettes as tobacco products while explicitly excluding heated tobacco products. If adopted, the law would take effect on February 1, 2026.
Dec.22 by 2FIRSTS.ai
Cambodia: Phnom Penh authorities seize 2,000+ vape devices and arrest two alleged distributors
Cambodia: Phnom Penh authorities seize 2,000+ vape devices and arrest two alleged distributors
Kiripost reports that authorities seized more than 2,000 electronic smoking devices and arrested two alleged distributors in Phnom Penh’s Toul Kork district, prompting health advocates to warn that inconsistent enforcement is undermining Cambodia’s crackdown on illegal e-cigarettes and shisha.
Jan.13 by 2FIRSTS.ai